Targeting of the Sp1 binding sites of HIV-1 long terminal repeat with chromomycin. Disruption of nuclear factor. DNA complexes and inhibition of in vitro transcription

Biochemical Pharmacology

Volumn 52, Issue 10, 1996, Pages 1489-1498

  Bianchi, Nicoletta ^a   Passadore, Marco ^a   Rutigliano, Cristina ^a   Feriotto, Giordana ^a   Mischiati, Carlo ^a   Gambari, Roberto ^a,b  

^a UNIVERSITY OF FERRARA   (Italy)

^b Dept of Biochem and Molec Biology ^*  (Italy)

Author keywords

chromomycin; DNA binding drugs; DNase I footprinting; HIV 1; in vitro transcription; transcription factors

Indexed keywords

CHROMOMYCIN;

ARTICLE; BINDING SITE; CONTROLLED STUDY; DNA BINDING; DNA TRANSCRIPTION; ELECTROPHORESIS; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

BASE SEQUENCE; BINDING SITES; CHROMOMYCINS; DNA; DNA FOOTPRINTING; DNA PRIMERS; HELA CELLS; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; JURKAT CELLS; NUCLEAR PROTEINS; NUCLEIC ACID SYNTHESIS INHIBITORS; POLYMERASE CHAIN REACTION; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC;

EID: 0030598375     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(96)00510-2     Document Type: Article

References (44)

1. 1. Berg OG and Von Hippel PH, Selection of DNA binding sites by regulatory proteins. Trends Biochem Sci 13: 207-211, 1988.
2. 2. Faisst S and Meyer S, Compilation of vertebrate-encoded transcription factors. Nucleic Acids Res 20: 3-26, 1992.
3. 3. Gaynor G, Cellular transcription factors involved in the regulation of HIV-1 gene expression. AIDS 6: 347-363, 1992.
4. 4. Lewin B, Oncogenic conversion by regulatory changes in transcription factors. Cell 64: 303-315, 1991.
5. 5. Weis L and Reinberg D, Transcription by RNA polymerase II: Initiator-directed formation of transcription-competent complexes. FASEB J 6: 3300-3309, 1992.
6. 6. Mitchell PJ and Tjian R, Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science 2: 371-378, 1989.
7. 7. Wingender E, Compilation of transcription regulatory proteins. Nucleic Acids Res 16: 357-369, 1988.
8. 8. Locker J, Transcription control: cis-elements and transfactors. In: Gene Transcription: A Practical Approach (Eds. Hamens BD and Higgins SJ), pp. 321-345. Oxford University Press, Oxford, 1993.
9. 9. Dervan PB, Design of sequence-specific DNA binding molecules. Science 232: 464-471, 1986.
10. 10. Broggini M, Ponti M, Ottolenghi S, D'Incalci M, Mongelli N and Mantovani R, Distamycins inhibit the binding of OTF-1 and NFE-1 transfactors to their conserved DNA elements. Nucleic Acids Res 17: 1051-1061, 1989.
11. 11. Weltch JJ, Rausher III FJ and Beerman TA, Targeting DNA-binding drugs to sequence-specific transcription factor · DNA complexes. J Biol Chem 269: 31051-31058, 1994.
12. 12. Dorn A, Affolter M, Muller M, Gehring WJ and Leupin W, Distamycin-induced inhibition of homeodomain-DNA complexes. EMBO J 11: 279-286, 1992.
13. 13. Feriotto G, Mischiati C and Gambari R, Sequence-specific recognition of the HIV-1 long terminal repeat by distamycin: A DNase I footprinting study. Biochem J 299: 451-458, 1994.
14. 14. Feriotto G, Ciucci A, Mischiati C, Animati F, Lombardi P, Giacomini P, Arcamone F and Gambari R, Binding of Epstein-Barr virus nuclear antigen 1 to DNA: Inhibition by distamycin and two novel distamycin analogues. Eur J Pharmacol 267: 143-149, 1994.
15. 15. Gambari R, Barbieri R, Nastruzzi C, Chiorboli V, Feriotto G, Natali PG, Giacomini G and Arcamone F, Distamycin inhibits the binding of a nuclear factor to the -278/-Z56 upstream sequence of the human HLA-DRα gene. Biochem Pharmacol 41: 495-502, 1991.
16. 16. Chiang S-Y, Welch J, Rausher FJ and Beerman TA, Effects of minor groove binding drugs on the interaction of TATA box binding protein and TFIIA with DNA. Biochemistry 33: 7033-7040, 1994.
17. 17. Bellorini M, Moncollin V, D'Incalci M, Mongelli N and Mantovani R, Distamycin A and tallimustine inhibit TBP binding and basal in vitro transcription. Nucleic Acids Res 23: 1657, 1995.
18. 18. Broggini M and D'Incalci M, Modulation of transcription factor-DNA interactions by anticancer drugs. Anti-Cancer Drug Des 9: 373, 1994.
19. 19. Ray R, Snyder RC, Thomas S, Koller CA and Miller DM, Mithramycin blocks protein binding and function of the SV40 early promoter. J Clin Invest 83: 2003-2007, 1989.
20. 20. Snyder RC, Ray R, Blume S and Miller DM, Mithramycin blocks transcriptional initiation of the c-myc P1 and P2 promoters. Biochemistry 30: 4290-4297, 1991.
21. 21. Gambari R and Nastruzzi C, DNA-binding activity and biological effects of aromatic polyamidines. Biochem Pharmacol 47: 599, 1994.
22. 22. Laughton C, Jenkins TC, Fox KR and Neidle S, Interaction of berenil with the tyrT DNA sequence studied by footprinting and molecular modelling. Implications for the design of sequence-specific DNA recognition agents. Nucleic Acids Res 18: 4479-4488, 1990.
23. 23. Churchill MEA, Hayes JJ and Tullius TD, Detection of drug binding to DNA by hydroxyl radical footprinting. Relationship of distamycin binding sites to DNA structure and positioned nucleosomes of 5S RNA genes of Xenopus. Biochemistry 29: 6043-6050, 1990.
24. 24. Gao X and Patel DJ, Solution structure of the chromomycin-DNA complex. Biochemistry 28: 751-762, 1989.
25. 25. Gao X and Patel DJ, Antitumor drug-DNA interactions: NMR studies of echinomycin and chromomycin complexes. Q Rev Biophys 22: 93-138, 1989.
26. 26. Van Dyke WW and Dervan PB, Chromomycin, mithramycin and olivomycin binding sites on heterogeneous deoxyribonucleic acid. Footprinting with (methidiumpropyl-EDTA)iron-(II). Biochemistry 22: 2373-2377, 1983.
27. 3-DNA interactions. Biochemistry 31: 9310-9318, 1992.
28. 28. Cons BMG and Fox KR, High resolution hydroxyl radical footprinting of the binding of mithramycin and related antibiotics to DNA. Nucleic Acids Res 17: 8695-8714, 1989.
29. 29. Fox KR and Howarth NR, Investigations into the sequence-selective binding of mithramycin and related ligands to DNA. Nucleic Acids Res 13: 8695-8714, 1985.
30. 30. Mote J, Ghanouni P and Reines D, A minor groove-binding ligand both potentiate and arrests transcription by RNA polymerase II. J Mol Biol 236: 725-737, 1994.
31. 31. McShean WM, Rossen RD, Laughter AH, Trial J, Kessler DJ, Zendegui JG, Hogan ME and Orson FM, Inhibition of transcription of HIV-1 in infected human cells by oligodeoxynucleotides designed to form DNA triple helices. J Biol Chem 267: 5712-5721, 1992.
32. 32. Li Y, Mak G and Franza BR, In vitro study of functional involvement of Sp1, NF-kB/Rel, and AP1 in phorbol 12-myristate 13-acetate-mediated HIV-1 long terminal repeat activation. J Biol Chem 269: 30616-30619, 1994.
33. 3 to DNA. Biochemistry 33: 1419-1424, 1994.
34. 34. Gualberto A and Baldwin AS, p53 and Sp1 interact and cooperate in the tumor necrosis factor-induced transcriptional activation of the HIV-1 long terminal repeat. J Biol Chem 270: 19680-19683, 1995.
35. 35. Mischiati C, Feriotto G, Bianchi N and Gambari R, A non-radioactive automated protocol to study protein-DNA interactions by DNase I footprinting. Int J Oncol 6: 153-156, 1995.
36. 36. Passadore M, Feriotto G, Bianchi N, Aguiari G, Mischiati C, Piva R and Gambari R, Polymerase-chain reaction as a tool for investigations on sequence-selectivity of DNA-drugs interactions. J Biochem Biophys Methods 29: 307-319, 1994.
37. 37. Passadore M, Bianchi N, Feriotto G, Mischiati C, Giacomini P, Piva R and Gambari R, Differential effects of distamycin analogues on amplification of human gene sequences by polymerase-chain reaction. Biochem J 308: 513-519, 1995.
38. 38. Sambrook J, Fritsch EF and Maniatis T, Molecular Cloning. A Laboratory Manual/II Edition. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1989.
39. 39. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB and Erlich HA, Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239: 487-491, 1988.
40. 40. Bianchi N, Passadore M, Feriotto G, Mischiati C, Gambari R and Piva R, Alteration of the expression of human estrogen receptor gene by distamycin. J Steroid Biochem Mol Biol 54: 211-215, 1995.
41. 41. Barbieri R, Giacomini P, Volinia S, Nastruzzi C, Mileo AM, Ferrini U, Soria M, Barrai I, Natali PG and Gambari R, Human HLA-DRα gene: A rare oligonucleotide (GTATA) identifies an upstream sequence required for nuclear protein binding. FEBS Lett 268: 51-54, 1990.
42. 42. Dignam JD, Lebovitz RM and Roeder RG, Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11: 1475-1489, 1983.
43. 43. Ciucci A, Feriotto G, Mischiati C, Gambari R, Animati F, Lombardi P, Natali PG, Arcamone F and Giacomini P, Distamycin analogues with improved sequence specific DNA binding activities. Biochem Pharmacol 48: 1583-1591, 1994.
44. 44. Majello B, De Luca P, Hagen G, Suske G and Lania L, Different members of the Sp1 multigene family exert opposite transcription regulation of the long terminal repeat of HIV-1. Nucleic Acids Res 22: 4914-4921, 1994.